stockportfolio.pro
Stocks / BKD vs RLAY
BKD vs RLAY
Brookdale Senior Living Inc. and Relay Therapeutics, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Brookdale Senior Living Inc. (BKD) | Relay Therapeutics, Inc. (RLAY) | |
|---|---|---|
| Market cap | $3.2B | $3.1B |
| Revenue (latest FY) | $3.19B | $15.36M |
| Net income (latest FY) | $-262.69M | $-276.48M |
| Revenue growth (5y CAGR) | -2.0% | -28.6% |
| Net margin | -8.2% | -1800.6% |
| Return on equity | 587.0% | -48.8% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BKD — free Open RLAY — freeFrequently asked questions
Which is bigger, BKD or RLAY?
Brookdale Senior Living Inc. is larger by market capitalization — $3.2B versus $3.1B.
Which grows faster, BKD or RLAY?
Over the last five fiscal years, Brookdale Senior Living Inc. grew revenue faster — -2.0%/yr versus -28.6%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.